NASDAQ: BRVE · Health Care / Biotechnology: Pharmaceutical Preparations

Braveheart Bio Inc.

How Braveheart Bio Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.9B

Price

$21.19

P/E

-5.4

EPS (TTM)

$-3.95

Dividend yield

0.0%

52-week range

$18.58–$21.87

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources